Glioma stem cells as a target for treatment
- PMID: 20737293
- DOI: 10.1007/s11523-010-0155-4
Glioma stem cells as a target for treatment
Abstract
Glioma cells with stem cell-like properties represent a minor subfraction of the total tumor cell population. These cells are highly chemo- and radioresistent and are held responsible for the inevitable recurrence of malignant gliomas. This review summarizes current strategies for targeting putative glioma stem cells. Target definition approaches comprise extrapolation and adaptation of therapies from general oncology, target identification by correlative molecular genetic analyses, and dedicated target discovery research. Targeting strategies include inhibition of tumor-specific signaling pathways, enhancement of tumor cell differentiation, radiosensitization, indirect targeting of the tumor stem cell niche, oncolytic virotherapy, and adhesion molecule blockade.
Similar articles
-
Targeting glioma stem cells: a novel framework for brain tumors.Cancer Sci. 2011 Nov;102(11):1958-66. doi: 10.1111/j.1349-7006.2011.02064.x. Epub 2011 Sep 16. Cancer Sci. 2011. PMID: 21848914 Free PMC article. Review.
-
Frontiers in targeting glioma stem cells.Eur J Cancer. 2011 Mar;47(4):496-507. doi: 10.1016/j.ejca.2010.11.017. Epub 2010 Dec 22. Eur J Cancer. 2011. PMID: 21185169 Review.
-
The role of glioma stem cells in chemotherapy resistance and glioblastoma multiforme recurrence.Expert Rev Neurother. 2015;15(7):741-52. doi: 10.1586/14737175.2015.1051968. Epub 2015 May 31. Expert Rev Neurother. 2015. PMID: 26027432 Free PMC article. Review.
-
In vitro screen of a small molecule inhibitor drug library identifies multiple compounds that synergize with oncolytic myxoma virus against human brain tumor-initiating cells.Neuro Oncol. 2015 Aug;17(8):1086-94. doi: 10.1093/neuonc/nou359. Epub 2015 Jan 20. Neuro Oncol. 2015. PMID: 25605818 Free PMC article.
-
[Chemotherapeutic treatment of gliomas increases the amount of cancer stem-like cells].Med Sci (Paris). 2009 Oct;25(10):775-7. doi: 10.1051/medsci/20092510775. Med Sci (Paris). 2009. PMID: 19849969 French. No abstract available.
Cited by
-
TRAIL and paclitaxel synergize to kill U87 cells and U87-derived stem-like cells in vitro.Int J Mol Sci. 2012;13(7):9142-9156. doi: 10.3390/ijms13079142. Epub 2012 Jul 20. Int J Mol Sci. 2012. PMID: 22942757 Free PMC article.
-
RNAi for contactin 2 inhibits proliferation of U87-glioma stem cells by downregulating AICD, EGFR, and HES1.Onco Targets Ther. 2017 Feb 13;10:791-801. doi: 10.2147/OTT.S113390. eCollection 2017. Onco Targets Ther. 2017. PMID: 28243115 Free PMC article.
-
EGFR Amplification and Glioblastoma Stem-Like Cells.Stem Cells Int. 2015;2015:427518. doi: 10.1155/2015/427518. Epub 2015 Jun 2. Stem Cells Int. 2015. PMID: 26136784 Free PMC article. Review.
-
Cancer-initiating enriched cell lines from human glioblastoma: preparing for drug discovery assays.Stem Cell Rev Rep. 2012 Mar;8(1):288-98. doi: 10.1007/s12015-011-9283-1. Stem Cell Rev Rep. 2012. PMID: 21717133 Review.
-
A BMP7 variant inhibits the tumorigenic potential of glioblastoma stem-like cells.Cell Death Differ. 2012 Oct;19(10):1644-54. doi: 10.1038/cdd.2012.44. Epub 2012 Apr 27. Cell Death Differ. 2012. PMID: 22539003 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical